NCT04471038 Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04460781 Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring Status COMPLETED Phase N/A
NCT04439695 Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT04377165 Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities Status TERMINATED Phase NA
NCT04365608 Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment Status COMPLETED Phase NA
NCT04363359 Clinical Trial of Quadrivalent Influenza Virus Split Vaccine Status COMPLETED Phase PHASE2
NCT04336020 The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study Status RECRUITING Phase N/A
NCT04327791 COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) Status COMPLETED Phase PHASE2/PHASE3
NCT04326309 Audio Data Collection for Identification and Classification of Coughing Status COMPLETED Phase N/A
NCT04323137 Encouraging Flu Vaccination Among High-Risk Patients Identified by ML Status COMPLETED Phase NA
NCT04297462 Different Regimens in Influenza Postexposure Chemoprophylaxis in Children Status UNKNOWN Phase NA
NCT04282135 Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling Status COMPLETED Phase N/A
NCT04250311 Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults Status SUSPENDED Phase PHASE3
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04223544 Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers Status UNKNOWN Phase N/A
NCT04210349 Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age Status COMPLETED Phase PHASE3
NCT04192500 Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years Status COMPLETED Phase PHASE2